je.st
news
Tag: 1st
US vs. EU Clothing Imports in 1st Quarter 2015: Origins (Quarterly Report)
2015-07-28 20:19:00| EmergingTextiles.com
US apparel imports have been much healthier than declining EU imports in the first quarter of 2015. The European Union market however remained by far larger than the US market. Vietnam has recorded a strong growth on both markets whereas Bangladesh has resisted. Our new quarterly report offers a 5-year comparison of US and EU apparel imports with volume, value and unit value changes from leading low-cost countries. The full table is also available for download.
Tags: report
1st
clothing
quarter
1st Half: BASF's Sales Up 3%, Net Income Down 10%
2015-07-27 10:30:18| Chemicals - Topix.net
"In the second quarter of 2015, we improved our sales and earnings despite lower growth in some markets and continuing volatile raw material prices. In the first half of 2015, our earnings matched the level of the first half of the previous year - in line with our full-year outlook," said Dr. Kurt Bock, Chairman of the Board of Executive Directors of BASF SE at the Half-Year Press Conference.
EU regulator recommends 1st license for malaria vaccine
2015-07-26 22:39:27| Biotech - Topix.net
In this Oct. 30, 2009 file photo, a mother holds her baby as she receives a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya.
Tags: license
1st
recommends
regulator
Bristol-Myers wins approval for 1st hepatitis C type 3 drug
2015-07-24 22:19:25| Biotech - Topix.net
An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus. Daklinza , developed by New York-based Bristol-Myers Squibb Co., is the first drug approved to treat genotype 3 hepatitis C. It's to be used with Sovaldi, one of two blockbuster hepatitis C drugs sold by Gilead Sciences, along with Harvoni.
EU drug regulator recommends 1st license for malaria shot
2015-07-24 14:00:19| Biotech - Topix.net
In this Oct. 30, 2009 file photo, a mother holds her baby as she receives a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya. The European Medicines Agency is recommending that the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time.
Sites : [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] next »